加速建设生物医药技术转移转化中心

Core Viewpoint - The proposal to accelerate the establishment of a technology transfer and transformation center for biomedicine aims to enhance the conversion of research achievements into practical applications, integrating capital and technology platforms [1]. Group 1: Suggestions for Establishing the Center - The establishment of a specialized technology transfer and transformation fund led by state-owned assets is suggested to serve as angel investment for project transfers [2]. - The creation or transformation of a physical biomedicine innovation research and development platform is recommended, which would integrate various specialized contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) to form a comprehensive and marketable innovation drug and device development platform [2]. - The formation of a professional team of technology managers is proposed to regularly select and evaluate research achievements nationwide, facilitating project assessment and investment decisions for the technology transfer center [2]. Group 2: Company Background and Initiatives - Sichuan Xiapai Sen Pharmaceutical Technology Co., Ltd., founded by Liu Jianyu, focuses on preclinical research services for innovative drugs, assisting multiple pharmaceutical companies in obtaining clinical research permits and achieving international licensing transactions [1]. - The company is part of Chengdu Medical City, where the emphasis on local transformation and collaborative development in the pharmaceutical and health industry is increasingly significant [1]. - Liu Jianyu has initiated the "Wenjiang District Medical City Laboratory Open Alliance," creating an online platform for sharing pharmaceutical innovation and research resources to promote healthy development in the regional pharmaceutical innovation ecosystem [1].